ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo.

about

ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo.

Item

http://www.wikidata.org/entity/Q41095538

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo.

@en

type

Item

label

ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo.

@en

prefLabel

ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo.

@en

P1476

ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo.

@en

P2093

Haimei Zhu

http://www.w3.org/2001/XMLSchema#string

Jianhui Wu

http://www.w3.org/2001/XMLSchema#string

Lin Gui

http://www.w3.org/2001/XMLSchema#string

Ming Zhao

http://www.w3.org/2001/XMLSchema#string

Shiqi Peng

http://www.w3.org/2001/XMLSchema#string

Xi Hu

http://www.w3.org/2001/XMLSchema#string

Xiaoyi Zhang

http://www.w3.org/2001/XMLSchema#string

Xinyi Xu

http://www.w3.org/2001/XMLSchema#string

Yaonan Wang

http://www.w3.org/2001/XMLSchema#string

Yuji Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Glucuronic acid and the ethanol metabolite ethyl-glucuronide cause toll-like receptor 4 activation and enhanced pain

Nanosized aspirin-Arg-Gly-Asp-Val: delivery of aspirin to thrombus by the target carrier Arg-Gly-Asp-Val tetrapeptide.

Influence of interleukin polymorphisms on development of gastric cancer and peptic ulcer

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems.

Stereoselective synthesis of a natural product inspired tetrahydroindolo[2,3-a]-quinolizine compound library.

Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models

Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies.

Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.

Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis.

Cell-selective intracellular drug delivery using doxorubicin and α-helical peptides conjugated to gold nanoparticles.

P304

4415-4431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S129989

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28652742

http://www.w3.org/2001/XMLSchema#string

P932

5476604

http://www.w3.org/2001/XMLSchema#string